文献速递神经肿瘤

PEPT2被鉴定为WHO II/III级胶质瘤5-ALA荧光引导手术的重要候选分子

Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
PubMed 文献 · J Neurooncol · 2019-03-30

该研究利用50例WHO II/III级胶质瘤手术标本,分析PpIX合成通路基因表达与术中5-ALA荧光状态的关系,发现荧光阳性胶质瘤中PEPT2的mRNA和蛋白表达显著高于荧光阴性者,siRNA下调PEPT2可降低PpIX荧光强度,提示PEPT2是5-ALA介导荧光的重要候选分子。

要点

  • 荧光阳性II/III级胶质瘤中PEPT2的mRNA和蛋白表达显著高于荧光阴性者。
  • siRNA下调PEPT2可降低SW-1783细胞中PpIX荧光强度。
  • PEPT2过表达与更高PpIX荧光强度相关,可能改善荧光引导切除。

核心结论

  • PEPT2是WHO II/III级胶质瘤5-ALA介导荧光引导手术的重要候选分子。
  • PEPT2过表达与更高的PpIX荧光强度相关,可能改善II/III级胶质瘤的荧光引导切除。

研究设计与样本

  • 使用50例诊断为WHO II级和III级胶质瘤的手术标本,根据术中5-ALA介导荧光状态分析PpIX合成通路基因表达以筛选候选分子。
  • 通过蛋白表达分析确认最可能候选基因,并在SW-1783人III级胶质瘤细胞系中使用特异性siRNA进行功能分析以评估该分子在PpIX合成中的生物学功能。

主要发现

  • 在卟啉合成通路相关基因中,荧光阳性胶质瘤的肽转运体2(PEPT2)mRNA表达显著高于荧光阴性胶质瘤。
  • Western blot和免疫荧光分析证实荧光阳性胶质瘤中PEPT2蛋白表达也显著更高。
  • siRNA介导下调PEPT2的mRNA和蛋白表达导致PpIX荧光强度降低,经荧光光谱分析确认。

临床怎么用

  • PEPT2表达状态可能作为判断WHO II/III级胶质瘤5-ALA荧光能否显现的候选分子标志。
  • PEPT2过表达与更高PpIX荧光强度相关,提示其可能改善荧光引导切除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: 5-aminolevulinic acid (5-ALA) fluorescence-guided surgery (FGS) appears to be a promising treatment for glioma. However, 5-ALA-mediated fluorescence cannot always be detected in grade II/III gliomas. We hypothesized that gene expression patterns in the Protoporphyrin IX (PpIX) synthesis pathway may be associated with intraoperative fluorescence status of grade II/III gliomas, and then attempted to identify the key molecule of 5-ALA-mediated fluorescence. METHODS: Using 50 surgically obtained specimens, which were diagnosed as grade II and III gliomas, we analyzed gene expression within the PpIX synthesis pathway to identify candidate molecules according to intraoperative 5-ALA-mediated fluorescence status. The most likely candidate gene was selected and confirmed by protein expression analysis. To evaluate the biological function of the molecule in PpIX synthesis, functional analysis was performed using specific, small interference (si)RNA in the SW-1783 human grade III glioma cell line. RESULTS: Among the genes involved in the porphyrin synthesis pathway, the mRNA expression of Peptide transporter 2 (PEPT2) in FGS fluorescence-positive gliomas was significantly higher than that in fluorescence-negative gliomas. Protein expression of PEPT2 was also significantly higher in the fluorescence-positive gliomas, which was confirmed by western blot analysis and immunofluorescence analysis. The siRNA-mediated downregulation of the mRNA and protein expression of PEPT2 led to decreased PpIX fluorescence intensity, as confirmed by fluorescence spectrum analysis. CONCLUSIONS: The results suggest PEPT2 is an important candidate molecule in 5-ALA-mediated FGS in grade II/III gliomas. As the overexpression of PEPT2 was associated with higher PpIX fluorescence intensity, PEPT2 may improve fluorescence-guided resection in grade II/III gliomas.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Hou C, Yamaguchi S, Ishi Y, et al. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas. J Neurooncol. 2019. PMID: 30929128. doi:10.1007/s11060-019-03158-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。